PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportspneumococcal meningitis
MeSH D008586 - pneumococcal meningitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D016920:Bacterial meningitis
101 Companies
29 Drugs
$
Success rate
D011008:Pneumococcal infections
37 Companies
8 Drugs
$
Success rate
D008586: 
Pneumococcal meningitis
36 Companies
3 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaVancomycin Vancomycin  2015-12-23   
MylanVancomycin Vancomycin  2008-12-30   
Lupin ResearchVancomycin Vancomycin  2015-01-28   
SandozVancomycin Vancomycin  2010-04-27   
Alkem LaboratoriesVancomycin Vancomycin  2022-11-14   
HospiraVancomycin Vancomycin  1988-08-04   
Amneal PharmaceuticalsVancomycin Vancomycin  2023-06-23   
Strides Pharma GlobalVancomycin Vancomycin  2012-04-09   
Lederle LaboratoriesVancomycin Vancoled  1993-10-15   
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
0%
0/1
Phase 3
100%
2/2
Approved: 2Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Mylan
Vancomycin
Pfizer
Meropenem
1
2
3
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use